Portfolio News October 13, 2014 Interleukin’s PerioPredict® Receives 2014 DrBicuspid Dental Excellence Award
Portfolio News October 8, 2014 Aciex Therapeutics Announces Issuance of Separate U.S. Patents Covering Two Leading Product Candidates
Portfolio News October 6, 2014 Sunesis Announces Results From Pivotal Phase 3 VALOR Trial of Vosaroxin and Cytarabine
Portfolio News September 29, 2014 EnteroMedics CE Mark for Obesity Expanded to Include Treatment of Type 2 Diabetes Mellitus
Portfolio News September 18, 2014 Merus’ MeMo® Mouse Patent Position Strengthened by Ruling of European Patent Office
Portfolio News September 3, 2014 EnteroMedics’ ReCharge Pivotal Trial Results Published in the Journal of the American Medical Association
Portfolio News August 28, 2014 EnteroMedics Announces Three Year Diabetes, Hypertension and Weight Loss Data from the Maestro(R) RC System DM2 ENABLE Study
Portfolio News August 27, 2014 Civitas Therapeutics Files Registration Statement for Proposed Initial Public Offering
Portfolio News August 19, 2014 Dermira Completes $51 Million Financing and Expands Management Team and Board of Directors
Portfolio News August 12, 2014 Epizyme Presents Pre-Clinical Data and Early Clinical Observations at ASH Meeting on Lymphoma Biology
Portfolio News July 9, 2014 Sunesis Pharmaceuticals Announces European Medicines Agency Acceptance of Pediatric Investigation Plan for Qinprezo(TM) (Vosaroxin) for AML
Portfolio News July 3, 2014 Dermira and UCB Enter Into Strategic Collaboration in ermatology to Broaden Patient Access to Cimzia® (certolizumab pegol)